Showing results (2141-2150 of 2,154) with videos related to

Sort By:
Pageof 216
Nature|February 14, 1998
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thalianaM Bevan, I Bancroft, E Bent, et al.
Plos One|February 10, 2025
Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R studyElizabeth C Oelsner, Akshaya Krishnaswamy, Rafail Rustamov, et al.
The American Journal of Psychiatry|February 13, 2020
Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric IllnessChristopher R K Ching, Boris A Gutman, Daqiang Sun, et al.
European Urology|February 1, 2020
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019Silke Gillessen, Gerhardt Attard, Tomasz M Beer, et al.
European Urology|April 8, 2022
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al.
European Urology|April 22, 2022
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021Silke Gillessen, Andrew Armstrong, Gert Attard, et al.
Nature|December 29, 2000
Sequence and analysis of chromosome 5 of the plant Arabidopsis thalianaS Tabata, T Kaneko, Y Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2023
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
European Urology|October 11, 2024
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)Silke Gillessen, Fabio Turco, Ian D Davis, et al.
European Urology|December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.
Pageof 216